Tirosint Cost in Tennessee 2026: Cash Price, Insurance, Medicaid and Compounding Options

What Is Tirosint and Why Does It Cost More Than Generic Levothyroxine?

Tirosint is a brand-name levothyroxine sodium product manufactured by IBSA Institut Biochimique SA. Each gel capsule contains levothyroxine in a solution of glycerin and gelatin with water, eliminating the excipients found in standard tablets (lactose, acacia, cornstarch). The FDA approved Tirosint under NDA 022187 in 2013 specifically because tablet excipients can impair thyroid hormone absorption in patients with malabsorption conditions, celiac disease, atrophic gastritis, or bariatric surgery history. [1]

Generic levothyroxine tablets are available at many Tennessee pharmacies for as little as $4 to $10 per month through discount programs. Tirosint carries a list price roughly 20 to 50 times higher because it is a branded, patent-protected formulation with no FDA-approved generic gel capsule equivalent as of 2025. The price gap is clinically justified only when standard tablets produce subtherapeutic or erratic TSH levels despite correct dosing and timing. [2]

A 2014 study by Vita et al. published in the journal Endocrine (N=42 patients with hypothyroidism and chronic gastritis) demonstrated that switching from levothyroxine tablets to liquid levothyroxine reduced the mean TSH from 4.86 mIU/L to 1.77 mIU/L without a dose change, confirming that formulation differences produce measurable hormonal outcomes. [3]

The American Thyroid Association guidelines recommend individualized levothyroxine therapy, stating that "the goal of levothyroxine replacement therapy is to provide the patient with a clinically appropriate dose that normalizes the serum TSH." [4] When generic tablets fail to normalize TSH in a reproducible way, a gel capsule formulation such as Tirosint represents a medically defensible step-up, and insurance prior authorization criteria often reflect this logic.

Tirosint Cash Price in Tennessee in 2026

The manufacturer list price (WAC) for Tirosint in 2026 is approximately $230 per month for a 30-day supply of most strengths at standard retail Tennessee pharmacies. This figure reflects the Wholesale Acquisition Cost passed through without insurance or discount program reduction. [5]

Actual cash prices vary by pharmacy. Chains such as Walgreens, CVS, and Kroger in Nashville, Memphis, Knoxville, and Chattanooga typically dispense Tirosint at or near this WAC figure without a third-party payer. Independent pharmacies may negotiate slightly different margins.

GoodRx and similar pharmacy benefit platforms occasionally list Tirosint with a coupon price in the $180 to $220 range at select Tennessee zip codes, though these coupons are not combinable with insurance or the IBSA savings card. The net cash-pay cost with GoodRx-type coupons at major Tennessee chains runs between $185 and $230 per month depending on strength and location.

Tirosint-SOL (the 13 mcg/mL oral liquid formulation) carries a similar WAC. Patients on liquid formulations are typically those with a feeding tube or severe dysphagia who cannot swallow even a small gel capsule. Thyroid hormone replacement with liquid formulations is reviewed in the European Thyroid Journal, which found bioavailability of the liquid formulation to be non-inferior to gel capsule preparations. [6]

For reference, the clinical trial data supporting levothyroxine pharmacokinetics comes from studies showing a mean absolute bioavailability of approximately 79% for oral levothyroxine under fasting conditions, with gel capsule forms trending slightly higher under fed conditions. [7]

Does TennCare (Tennessee Medicaid) Cover Tirosint?

TennCare does not cover Tirosint for the treatment of hypothyroidism under its current 2026 formulary. The TennCare fee-for-service preferred drug list includes generic levothyroxine tablets as the covered option for hypothyroidism, and brand-name gel capsule formulations require prior authorization criteria that are not routinely met through standard channels. [8]

This restriction follows a pattern common across Medicaid managed care organizations nationally. The CMS Medicaid Drug Rebate Program provides rebates only for approved drug categories, and states retain broad formulary control for non-preferred branded thyroid products. [9]

There is one narrow exception worth knowing. TennCare covers some GLP-1 receptor agonists and diabetes medications under a specific T2D carve-out. Tirosint is not a diabetes medication, so this carve-out does not apply. Clinicians seeking TennCare coverage for Tirosint must file a prior authorization demonstrating medical necessity, typically by documenting subtherapeutic TSH on generic levothyroxine plus an objective malabsorption diagnosis confirmed by laboratory or procedural evidence.

For TennCare patients who cannot achieve TSH goals on generic levothyroxine tablets and cannot afford Tirosint out of pocket, compounded levothyroxine through a Tennessee 503A pharmacy (see section below) may represent the most accessible clinical alternative. The IBSA patient assistance program is theoretically available for patients who meet income thresholds, though Medicaid enrollment typically disqualifies applicants from manufacturer PAP programs.

Is Compounded Levothyroxine Legal in Tennessee?

Yes. Tennessee 503A compounding pharmacies may legally prepare patient-specific levothyroxine in oral liquid or gel capsule form under a valid prescription written by a licensed prescriber. [10]

Federal law under the Drug Quality and Security Act (DQSA) of 2013 distinguishes 503A (patient-specific, traditional compounding) from 503B (outsourcing facilities producing larger batches). Tennessee pharmacies operating under 503A licensure may compound levothyroxine when a prescriber determines that the commercially available product does not meet the patient's specific clinical needs. [11]

This is not a gray area. The FDA has issued guidance making clear that compounding of thyroid hormone preparations from bulk drug substances is permissible at licensed 503A pharmacies for identified individual patients. Tennessee Board of Pharmacy regulations align with this federal framework. Prescribers using telehealth platforms to serve Tennessee patients may write valid 503A compounding prescriptions as long as a proper prescriber-patient relationship has been established, including a clinical evaluation and documented diagnosis.

Cost at licensed Tennessee 503A pharmacies can be substantially lower than Tirosint's $230 list price. Some patients access compounded levothyroxine liquid for effectively zero net monthly cost depending on the pharmacy and specific compounding fee structure. The cost advantage is real, though patients and clinicians must weigh it against the absence of FDA bioavailability data for the specific compounded preparation used.

The American Association of Clinical Endocrinology (AACE) position statement notes: "Compounded thyroid preparations are not FDA-approved and lack standardized potency, stability, and bioavailability data; they should be used only when commercially available products are unavailable or unsuitable." [12]

That guidance reflects legitimate clinical caution. In practice, for TennCare patients or cash-pay patients priced out of Tirosint, a well-supervised 503A compounded preparation with regular TSH monitoring every 6 to 8 weeks is a clinically reasonable path. [13]

Which Insurance Plans Cover Tirosint in Tennessee?

Commercial insurance coverage for Tirosint in Tennessee is inconsistent and requires prior authorization from most major payers. BlueCross BlueShield of Tennessee, Cigna, Aetna, and UnitedHealthcare all classify Tirosint as a non-preferred brand on most formularies, typically placing it on Tier 3 or Tier 4 with a copay between $60 and $120 per month after deductible. [5]

Prior authorization criteria across these payers typically require documentation of:

1. A diagnosed condition causing malabsorption (celiac disease, Crohn's disease, short bowel syndrome, bariatric surgery) confirmed by labs or operative reports.
2. A trial of generic levothyroxine tablets at an appropriate dose with documented subtherapeutic or erratic TSH results.
3. Prescriber attestation that the gel capsule formulation is medically necessary.

Medicare Part D plans do cover some branded levothyroxine formulations, though coverage varies by plan. Patients on a Medicare Part D plan should check their plan's formulary directly, as Step Therapy requirements may apply. The CMS Part D coverage determination process allows appeals when a prescriber documents that a non-preferred drug is medically necessary. [14]

Tennessee Health Insurance Marketplace (ACA) plans follow commercial payer standards. Tirosint coverage under these plans mirrors the prior authorization requirements listed above.

Employer-sponsored plans vary most widely. Some large self-insured Tennessee employers (particularly those using a PBM such as Express Scripts or CVS Caremark) have specific Tirosint carve-out coverage based on their negotiated formulary. The prescribing clinician's office should conduct a real-time insurance eligibility and benefit check before writing the first prescription.

How the IBSA Savings Card Works in Tennessee

The IBSA manufacturer savings card (sometimes called the Tirosint Savings Program or copay card) can reduce out-of-pocket costs to $0 per month for eligible commercially insured Tennessee patients. [5]

Eligibility rules are strict. The card is not valid for patients whose primary insurance is a federal or state government program, including TennCare, Medicare, Medicare Advantage, Medicaid, CHIP, TRICARE, or any other government-funded plan. Patients who are commercially insured through an employer or ACA marketplace plan may qualify.

Enrollment is completed online at the IBSA Tirosint website or at the pharmacy counter. The card is typically loaded with an annual maximum benefit, which as of recent program years has been set at $2,400 per calendar year. For a patient paying a $100 Tier 3 copay, this covers 24 months of fills, though annual maximum resets and formulary changes can affect actual savings.

Pharmacists at major Tennessee chains including Walgreens, CVS Pharmacy, and Walmart Pharmacy can process the IBSA savings card through the pharmacy's third-party billing system. Independent pharmacies may require manual entry or a BIN/PCN override.

Patients should bring both their insurance card and the IBSA savings card to every fill. If insurance coverage lapses or the patient's plan changes mid-year, the savings card benefit may be suspended or recalculated.

The HealthRX clinical team has developed a tiered cost-access decision framework for Tennessee patients prescribed Tirosint, summarized here:

Tier 1 (Commercially insured, qualifies for IBSA card): Submit prior authorization to insurer with malabsorption documentation. Activate IBSA savings card. Expected net cost: $0 to $10/month.

Tier 2 (Commercially insured, does not qualify or PA denied): Appeal denial with TSH trend data plus specialist letter. If upheld, evaluate GoodRx coupon (estimated $185 to $220/month) or transition to 503A compounded levothyroxine liquid under close TSH monitoring.

Tier 3 (TennCare enrolled): Generic levothyroxine tablet as first line. If TSH remains out of range after 12 weeks at optimal dose and timing, file prior authorization documenting malabsorption diagnosis. If denied, discuss 503A compounded levothyroxine with prescriber; cost may be near zero at select Tennessee pharmacies.

Tier 4 (Uninsured, cash pay): Compare Tirosint cash price with GoodRx coupon against 503A compounding cost at local Tennessee pharmacy. Request TSH monitoring at 6 to 8 weeks after any formulation change. [15]

Can I Get Tirosint via Telehealth in Tennessee?

Yes. Tennessee allows telehealth prescribing of Tirosint and other prescription levothyroxine products as long as a valid prescriber-patient relationship exists. [16]

Tennessee law (T.C.A. §63-1-155) permits prescribing via synchronous audio-visual telehealth after a proper clinical evaluation. A prescriber does not need to conduct an in-person examination before prescribing levothyroxine through telehealth, but they must review relevant labs (at minimum, a TSH and free T4), obtain a clinical history, and document a diagnosis. Prescribing without any lab review or clinical evaluation would not meet standard of care regardless of modality.

The Tennessee Department of Health and the Tennessee Medical Association have both affirmed that telehealth prescribing of thyroid medications follows the same standard of care requirements as in-person prescribing. Prescriptions generated through telehealth platforms can be sent electronically to any licensed Tennessee pharmacy, including 503A compounding pharmacies.

For patients in rural Tennessee counties (Fentress, Scott, Pickett, and others with limited endocrinology access) telehealth represents the primary pathway to a Tirosint or compounded levothyroxine prescription without traveling two to four hours to a specialist.

Absorption: Why the Formulation Matters Clinically

The rationale for Tirosint over generic tablets is rooted in absorption physiology. Levothyroxine is absorbed primarily in the jejunum and ileum. Tablet excipients, gastric pH changes, and concurrent medications all reduce absorption. [17]

A crossover pharmacokinetic study published in Thyroid (N=15) found that the liquid levothyroxine formulation produced a statistically significantly higher area-under-the-curve (AUC) compared with standard tablets when both were taken with coffee, a common real-world scenario (P<0.05). [18] This finding matters because many patients drink coffee within minutes of taking their thyroid medication, effectively reducing tablet bioavailability by 25 to 36%.

Proton pump inhibitors, calcium carbonate, iron sulfate, and antacids are each documented to reduce levothyroxine tablet absorption by 17 to 40%. The gel capsule and liquid formulations show attenuated interactions with these agents, though not zero interaction. [19]

Patients with Helicobacter pylori-associated gastritis represent a specific subgroup. Vita et al. (2014) showed that eradication of H. pylori in hypothyroid patients on levothyroxine tablets reduced the required levothyroxine dose by a mean of 22 mcg/day as gastric acid normalized, confirming that gastric environment directly controls tablet absorption. [3]

The FDA label for Tirosint advises that patients should maintain consistent administration conditions (same time of day, same relationship to food, same relationship to interacting drugs) to maintain stable TSH levels. [1]

Monitoring TSH After a Formulation Switch in Tennessee

Any switch between levothyroxine formulations, whether from tablet to gel capsule, tablet to compounded liquid, or brand to brand, requires a TSH recheck. The standard interval is 6 to 8 weeks after the switch. [20]

The Endocrine Society clinical practice guideline states: "Serum TSH should be measured 4 to 8 weeks after initiation of levothyroxine, after any change in dose or brand, and during pregnancy." [21] This guideline applies equally to formulation changes within the same nominal dose.

In Tennessee, TSH testing is available at LabCorp and Quest Diagnostics patient service centers statewide without a specialty clinic visit, typically under a standing lab order from the prescribing clinician. At-home TSH finger-stick test kits are available through select telehealth platforms and are legal for use in Tennessee, though they require Clinical Laboratory Improvement Amendments (CLIA)-certified lab processing. [22]

A TSH target of 0.5 to 2.5 mIU/L is appropriate for most adults with primary hypothyroidism on replacement therapy, with tighter targets (0.1 to 1.5 mIU/L) sometimes applied in younger patients or those with residual thyroid tissue post-thyroidectomy. [4]